Learn More
4552 Background: Everolimus (EVE, Afinitor) was approved for treatment of patients with metastatic renal cell cancer (mRCC) after failure of anti-VEGF therapy. Nevertheless, only limited prospective(More)
4064 Background: Combinations of irinotecan (CPT11) with continuous folinic acid (FA) and 5-fluorouracil (5-FU) have shown promising activity in advanced or metastatic gastric cancer (AGC). We(More)